Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-19 | COINSHARES INTERNATIONAL LIMITED | Daniel Masters | Chairman of the Board of Directors | Acquisition | 9 052 | 91,7 | SEK | 830 068,4 | 2025-01-16 |
| 2025-01-19 | COINSHARES INTERNATIONAL LIMITED | Daniel Masters | Chairman of the Board of Directors | Acquisition | 27 920 | 86,81 | SEK | 2 423 735,2 | 2025-01-14 |
| 2025-01-19 | Hunter Capital AB | Oliver Aleksov | Chairman of the Board of Directors | Internal transaction – Disposal | 50 279 | 4,2 | SEK | 211 171,8 | 2025-01-14 |
| 2025-01-19 | Hunter Capital AB | Oliver Aleksov | Chairman of the Board of Directors | Internal transaction – Acquisition | 50 279 | 4,2 | SEK | 211 171,8 | 2025-01-14 |
| 2025-01-19 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Disposal | 1 519 932 | 0,171 | SEK | 260 212,358 | 2025-01-15 |
| 2025-01-19 | Xbrane Biopharma AB | Siavash Bashiri | Deputy CEO/Deputy Managing Director | Acquisition | 1 500 000 | 0,171 | SEK | 256 500 | 2025-01-15 |
| 2025-01-20 | Hunter Capital AB (publ) | Milad Pournouri | Other senior executive | Internal transaction – Disposal | 50 280 | 3,66 | SEK | 184 024,8 | 2025-01-16 |
| 2025-01-20 | Hunter Capital AB (publ) | Milad Pournouri | Other senior executive | Internal transaction – Acquisition | 50 280 | 3,66 | SEK | 184 024,8 | 2025-01-16 |
| 2025-01-20 | Smart Eye Aktiebolag (publ) | Martin Krantz | Chief Executive Officer (CEO)/Managing Directory | Disposal | 53 052 | 57,74 | SEK | 3 063 222,48 | 2025-01-16 |
| 2025-01-20 | Reato Group AB (publ) | Pål Morch | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 34 100 | 0,33 | SEK | 11 253 | 2025-01-15 |
| 2025-01-20 | Reato Group AB (publ) | Pål Morch | Chief Executive Officer (CEO)/Managing Directory | Loan received | 2 800 000 | 0,33 | SEK | 924 000 | 2025-01-15 |
| 2025-01-20 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 500 000 | 0,171 | SEK | 256 500 | 2025-01-15 |
| 2025-01-20 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 500 000 | 0,171 | SEK | 256 500 | 2025-01-15 |
| 2025-01-20 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 864 223 | 0,171 | SEK | 318 782,133 | 2025-01-16 |
| 2025-01-20 | Xbrane Biopharma AB | Karl Martin Erik Åmark | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 864 223 | 0,169 | SEK | 315 053,687 | 2025-01-16 |
| 2025-01-20 | Resurs Holding AB (publ) | Martin Iacoponi | Member of the Board of Directors | Acquisition | 110 | 23,5 | SEK | 2 585 | 2025-01-16 |
| 2025-01-20 | NYAB AB | Johan Larsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 3 300 | 5,13 | SEK | 16 929 | 2025-01-19 |
| 2025-01-20 | NYAB AB | Johan Larsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 53 700 | 5,05 | SEK | 271 185 | 2025-01-16 |
| 2025-01-20 | NordLei | Lars Roth | Other member of the company's administrative, management or supervisory body | Acquisition | 30 000 | 2,58 | SEK | 77 400 | 2025-01-14 |
| 2025-01-20 | NordLei | Lars Roth | Other member of the company's administrative, management or supervisory body | Acquisition | 19 534 | 2,66 | SEK | 51 960,44 | 2025-01-15 |